Higher cerebrospinal fluid gadolinium concentrations were detected within the first eight hours after gadolinium-based contrast agent administration.
Gadoterate meglumine, a gadolinium-based contrast agent (GBCA) can be detected in human cerebrospinal fluid (CSF) after intravenous administration for MR imaging, according to a study published in the journal Radiology.
Researchers from Switzerland performed a retrospective study to evaluate whether gadolinium penetrated SCF after MR imaging with GBCA.
The researchers analyzed 60 CSF samples from 57 patients (median age, 50 years) who underwent one contrast material–enhanced MRI examination with gadoterate meglumine within 60 days of CSF extraction between January and December 2016:
• Group 1: 31 samples acquired between 0 and 8 hours after MRI
• Group 2: 13 samples acquired 8 to 48 hours after MRI
• Group 3: 16 samples acquired 2 to 60 days after MRI
There were also 24 subjects (median age, 60.5 years) who served as a control group. Of this group, 22 had not received contrast with MRI, while the other two had GBCA-enhanced MRI scans one and three years, respectively, before CSF samples were taken.
The results showed higher CSF gadolinium concentrations were detected within the first eight hours after GBCA administration.
• Group 1: Mean concentration was 1,152 ng/mL ± 734.6
• Group 2: Mean concentration was 872 ng/mL ± 586
• Group 3: Mean concentration was 121 ng/mL ± 296.3
All but two samples from the 24 control patients were negative for the presence of gadolinium, the researchers noted. Those samples were from patients who had undergone GBCA-enhanced MRI examination more than a year before CSF extraction (0.1 and 0.2 ng/mL after one and three years, respectively). The concentrations in three patients with chronic renal insufficiency, one with cerebral toxoplasmosis, and one with liver cirrhosis were higher than the mean concentrations.
The researchers concluded that gadoterate meglumine can be detected in human CSF after intravenous administration.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
The Reading Room Podcast: Emerging Trends in the Radiology Workforce
February 11th 2022Richard Duszak, MD, and Mina Makary, MD, discuss a number of issues, ranging from demographic trends and NPRPs to physician burnout and medical student recruitment, that figure to impact the radiology workforce now and in the near future.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Burnout in Radiology: Key Risk Factors and Promising Solutions
June 9th 2025Recognizing the daunting combination of increasing imaging volume and workforce shortages, these authors discuss key risk factors contributing to burnout and moral injury in radiology, and potential solutions to help preserve well-being among radiologists.